← Insider buys

Mehmood Khan has bought stock on 5 days since Aug 2017

Director at International Flavors & Fragrances Inc., and 2 other companies

SEC CIK 0001505888 · Filings on SEC.gov ↗

$830KBought
$31.4MSold
May 15Last buy

Mehmood Khan's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Companies

Every filing

8 filings since Jul 2016, newest first

About Mehmood Khan

Mehmood Khan, M.D. is a director of International Flavors & Fragrances Inc. (IFF) and a veteran global R&D and health-science executive.( He serves as CEO of the Hevolution Foundation, a global non-profit focused on extending healthy human lifespan through grants and early-stage investments in healthspan science, and sits on the IFF Board of Directors, where he contributes deep expertise in innovation, life sciences, and sustainability.( As an IFF director, he has recently been reported as acquiring additional IFF common shares in open-market transactions, reflecting his status as a corporate insider.(

Dr. Khan’s prior leadership roles include serving as Executive Chair and earlier CEO of Life Biosciences, Vice Chairman and Chief Scientific Officer of Global R&D at PepsiCo, and President of Global R&D at Takeda Pharmaceuticals, following an academic and clinical career in endocrinology at the Mayo Clinic and Hennepin County Medical Center.( He serves or has served on multiple boards and advisory bodies, including the Saudi Research, Development, and Innovation Authority, the Saudi National Biotechnology Strategy Steering Committee, and previously Reckitt Benckiser’s board and the U.S. National Institute of Standards and Technology Visiting Committee on Advanced Technology.( Dr. Khan earned his medical degree from the University of Liverpool School of Medicine and completed a fellowship in clinical endocrinology and nutrition at the University of Minnesota, and he is a Fellow of the Royal College of Physicians (London) and the American College of Endocrinology.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.